Core Viewpoint - Recent adjustments in Asian stock markets, cryptocurrencies, and commodities are primarily driven by the nomination of Warsh as the Federal Reserve Chairman, which has impacted liquidity expectations. However, the underlying cause is the prior overly optimistic trading environment, leading speculative funds to take profits amid negative events [1][2]. Group 1: Market Adjustments - The global asset adjustment is correlated with the nomination of Warsh, with a significant negative correlation between the cumulative adjustment since January 30 and the year-to-date performance of major global indices and commodities [2]. - The Hong Kong stock market sentiment index approached the upper limit of 70%, and the future 12-month PE valuation returned to levels seen before October of the previous year, indicating a strong market sentiment [5]. Group 2: A-Share Market Outlook - The A-share market's rise since the beginning of the year is supported by favorable domestic fundamentals, a "New Year" policy boost, and ample liquidity, which are expected to continue driving the spring market [7]. - Key drivers for the spring market include the verification of performance improvement trends through annual report forecasts, macro data releases in February, and a surge in AI applications, which are anticipated to provide structural guidance for further market development [7]. Group 3: Catalysts and Industry Focus - A series of industry catalysts are scheduled for February, including OPEC meetings, AI application events, and significant earnings reports from major companies, which could influence market dynamics [10]. - The AI application sector is expected to see concentrated catalysts in February, with current levels of crowding deemed reasonable, suggesting an opportunity for increased focus during this fundamental gap period [12]. Group 4: Investment Themes - Investment themes to watch include high-performing technology manufacturing sectors (AI hardware, new energy, pharmaceuticals), price increase chains (oil, chemicals, construction materials), and the Spring Festival consumption chain (tourism, hotels, beverages) [10]. - Non-bank financials, particularly brokers and insurance companies, may have potential for recovery after being negatively impacted by broad ETF outflows, indicating a favorable outlook for these sectors [10].

Core Viewpoint - The recent nomination of Warsh has triggered a global asset adjustment, with significant correlations observed between the cumulative adjustment since January 30 and the year-to-date performance of major global indices and commodities [1][23]. Group 1: Market Reactions - Asian stock markets, cryptocurrencies, and commodities have experienced notable risk adjustments, primarily attributed to liquidity expectations following Warsh's nomination as Fed Chair, but fundamentally driven by prior overly optimistic trading conditions [1][23]. - The Hong Kong stock market sentiment index approached the upper threshold of 70%, with future 12-month PE valuations returning to pre-October highs from the previous year, alongside record highs in precious metals and the South Korean stock market [2][25]. Group 2: Future Outlook - Warsh's short-term impact on asset prices is expected to be more narrative and emotional, with limited substantial influence on existing Fed monetary policy paths, as factors like U.S. employment, inflation, and liquidity in the repurchase market remain critical [6][26]. - For A-shares, the year-to-date increase is supported by favorable domestic fundamentals, a "good start" policy, and ample liquidity, with core drivers for the spring market remaining unchanged [6][28]. Group 3: Investment Opportunities - Focus on sectors with lower recent gains but strong logical support, such as high-performing technology manufacturing, AI applications, and the price increase chain, which includes oil and domestic-driven sectors [8][32][37]. - The AI application sector is highlighted for its potential, with a dense catalyst period in February and a reasonable level of crowding, making it a focal point during the fundamental gap [10][34].

金价继续跳水：部分银行实物金条库存悄然松动 投资情绪降温 黄金、白银价格继续剧烈波动，随着黄金、白银价格持续大幅下挫，人们投资实物黄金的热情有所松 动，部分投资者选择观望，此前日日被抢断货的银行金条也出现了库存，部分银行的实物金条甚至显示 为"库存充足"状态。业内普遍认为，本次黄金"巨震"，直接原因或是美国总统特朗普提名凯文·沃什为 新任美联储主席，导致"独立性危机"担忧降温，美元反弹。（一财） 黄金一度暴跌1000美元 业内提示警惕抄底风险 黄金大幅下跌，伦敦现货金距离1月29日高点跌幅一度超过1000美元/盎司。业内人士认为，黄金短期内 将会大幅震荡，建议投资者先不要急于抄底，等市场波动幅度降低后，黄金ETF等产品将会比金矿股更 加稳健，目前看黄金中长期的投资逻辑依然维持，但也要关注美联储主席换人之后，如何配合总统特朗 普的政策变化。光大证券国际策略师伍礼贤表示，黄金本质上属于避险资产，然而任何资产价格出现大 幅波动时，其风险属性将随之显现，在经历近期急剧下跌行情后，预计短期价格波动或将延续。此次回 落的重要支撑位置大致位于4300美元/盎司至4500美元/盎司区间，投资者当前不宜急于抄底。（一财） 招商 ...

医药企业近日陆续披露年报预告，据东方财富Choice数据统计，截至目前，A股医药生物板块有137家 企业预告2025年亏损，其中首亏、增亏的企业数量占比一半以上；而预计去年归属于母公司的净利润亏 损最高的，达到137亿元。 药企亏损的背后，受制于多方面因素，其中产品价格下跌成为高频词。 亏损最高的超百亿 具体看这137家预告亏损的医药生物企业，涵盖了原料药、化学制剂、中药、疫苗、医药流通、体外诊 断、医疗耗材、医疗研发外包、医疗设备等细分领域，从预告归属于母公司的净利润下限指标看，亏损 最大的是智飞生物（300122.SZ），去年业绩首亏，公司预计归属于母公司的净利润亏损最高可达到 137.26亿元；紧接着是珍宝岛（603567.SH），预计去年归属于母公司的净利润亏损最高可达到11.73亿 元；之后是百利天恒（688506.SH），预计去年归属于母公司的净利润亏损最高可达到11亿元。 另外，蓝帆医疗（002382.SZ）、神州细胞（688520.SH）、润达医疗（603108.SH）、广济药业 （000952.SZ）这四家企业预计去年归属于母公司的净利润亏损最高可超过5亿元。 A股医药生物板块企业的亏损，受 ...

2月2日，2026年春运大幕开启。北京朝阳站交通枢纽内，旅客们惊喜地发现，全聚德、同仁堂、张一 元、百年义利等十余家中华老字号品牌携经典产品集中亮相，让旅客们可以在上车前带走一份北京礼 物。从2月2日至元宵节前后，将有120余场活动在"八站两场"地区接续上演。 今年，市重点站区管委会推进春节市场"文商旅展"融合发展，设计"'京'彩站区·精彩汇集"新春老字号非 遗市集、"书香站区"全民阅读活动、"博物馆进站区"文博活动、文艺快闪互动演出、"旅客身边人"服务 保障五大板块，从2月2日至元宵节前后，共计120余场活动在"八站两场"地区接续上演。 "旅客可以在北京站候车大厅欣赏体验珐琅彩的非遗工艺，与南站地区'福马送春'景观花灯打卡拍照， 在北京北站、北京清河站地区邂逅延庆区非遗民俗表演，在副中心交通枢纽的生肖展、年画展里品味传 统文化创新表达……"市重点站区管委会宣传处处长李钒说，让每一位市民旅客在归途中感受首都温 度，在旅途中邂逅文化之美，满怀喜悦奔赴万家灯火里的团圆时刻。 来源：北 京日报客户端 记者注意到，现场70余个摊位全部启用，除老字号品牌外，密云、怀柔、平谷等北京远郊区县也带来自 己的特产，还有滑雪度假 ...

Core Viewpoint - The article discusses a case of corruption involving a hospital director in Ankang City, Shaanxi Province, who was found guilty of accepting bribes totaling 2,720,548 yuan from medical suppliers, highlighting issues of medical commercial bribery and its impact on healthcare costs and competition [2][5]. Group 1: Case Details - The hospital director, Li, accepted a total of 2,720,548 yuan in bribes from various medical suppliers, including 2,468,958 yuan from supplier Jia for medical consumables, which was used for personal expenses such as purchasing and renovating a villa [2][3]. - Li also received 231,580 yuan from supplier Sun, who promised a 30% kickback on the total supply amount, which Li used to repay personal loans [3]. - Additionally, Li accepted 20,010 yuan from pharmaceutical supplier Jiang, which he used to promote a specific drug within the hospital [4]. Group 2: Implications of Corruption - The case illustrates how medical commercial bribery undermines fair competition and increases healthcare costs, as the kickback system distorts the procurement process, leading to inflated prices for medical supplies [5]. - The article emphasizes the necessity for centralized procurement of orthopedic consumables to mitigate such corrupt practices and ensure the integrity of the healthcare system [6].

Market Overview - A-shares experienced a collective pullback with the Shanghai Composite Index down by 1.32% in the morning session [1] - The Hong Kong stock market saw a significant decline, with the Hang Seng China Enterprises Index dropping by 2.7% [1][3] Index Performance - The CSI 300 Index fell by 1.1%, with a rolling P/E ratio of 14.2 times, placing it in the 64.8th percentile since its inception in 2005 [2] - The CSI A500 Index decreased by 1.4%, with a rolling P/E ratio of 17.4 times, ranking in the 76.4th percentile since 2004 [2] - The ChiNext Index dropped by 1.2%, with a rolling P/E ratio of 42.6 times, which is in the 40.9th percentile since its launch in 2010 [2] - The STAR Market 50 Index declined by 2.2%, with a rolling P/E ratio of 174.1 times, placing it in the 96.5th percentile since 2020 [2] Sector Performance - Active sectors included liquor, internet, cultural media, and banking, while sectors such as precious metals, non-ferrous metals, petrochemicals, coal, and steel saw the largest declines [1]

Summary of Key Points from Conference Call Records Industry Overview Alcohol Industry - The liquor sector, particularly the baijiu segment, has shown strong performance leading up to the Spring Festival, with Moutai's sales exceeding expectations and institutional holdings at a historical low of 3.5% [1][3] - Moutai's price has increased from 1,550 RMB to 1,700 RMB, with expectations for further price increases before the festival, maintaining a price floor above 1,500 RMB for the year [3] - Recommended stocks include Moutai, Wuliangye, and Fenjiu, with Moutai being the top pick due to its attractive valuation and dividend yield above 4% [1][4] Agriculture Industry - Haida Group is projected to achieve a compound annual growth rate (CAGR) of 10%-15% in its domestic feed business over the next 5-10 years, with overseas market growth exceeding 40% [1][6] - The company plans to reduce capital expenditures to lower per-ton depreciation costs, thereby releasing profits [6] - In the pig farming sector, the focus is on the breeding sow inventory, which has decreased by 1.8% year-on-year, indicating a potential rebound in pig prices post-adjustment in production capacity [8][9] Pharmaceutical Industry - The pharmaceutical sector is experiencing a multi-point development trend, with promising prospects in innovative drugs and AI healthcare [11] - Retail pharmacy growth is expected to be between 10%-15%, supported by government policies encouraging high-quality development in the sector [12] - The market confidence is recovering, with opportunities in traditional Chinese medicine and retail pharmacy expected to increase due to improved inventory and consumption characteristics [12][13] Home Appliance Industry - The home appliance sector is benefiting from signals of financial easing in real estate, with major brands like Midea and Haier entering a price increase cycle [14] - Midea's dividend rate may increase to 75% by 2025, with a projected dynamic PE of 12-13 times for 2026 [14] - The LCD panel market is also seeing price increases, with TCL Technology expected to double its earnings in 2026 due to the expiration of depreciation on its panels [14] Textile and Apparel Industry - Li Ning Company is highlighted as a key investment target, with inventory levels returning to 4.5-5 months and positive cash flow from distributors [15][16] - The company has entered a technology upgrade cycle, with strong feedback on new running shoe lines and a partnership with the Chinese Olympic Committee to sponsor the national team's uniforms [16][17] E-commerce and Cloud Computing - Alibaba is viewed positively for its AI and cloud computing businesses, with expectations for rapid user growth in its Q&A app and potential price increases in its cloud services [18] - The target price for Alibaba is set at 194 HKD, with a valuation of at least 10 times PE for its e-commerce business and 10 times PS for its cloud business [18] Snack Industry - The bulk snack industry is in a high-growth phase, with a market size of approximately 60,000 stores and potential for 50% growth [20] - Recommended companies include Mingming Hen Mang and Wancheng Group, with expected revenue growth rates exceeding 20% and profit growth around 30% [20] Additional Insights - The overall market sentiment is shifting towards consumer sectors, with a focus on increasing consumption rates in China as a key economic goal [2] - The anticipated recovery in various sectors, including pharmaceuticals and home appliances, suggests a favorable environment for investment in these industries [11][14]

Investment Rating - The report maintains an "Outperform" rating for multiple companies in the healthcare sector, including BeiGene, JD Health, WuXi Biologics, and others, while China National Pharmaceutical Group is rated "Neutral" [1]. Core Insights - The Hong Kong healthcare sector experienced a broad-based correction due to capital pressures, with pharmaceutical distribution remaining relatively stable [4][28]. - The Hang Seng Healthcare Index fell by 3.0% this week, underperforming the Hang Seng Index by 5.4 percentage points, but has gained 8.6% year-to-date, outperforming the Hang Seng Index by 1.7 percentage points [14][27]. - The top five gainers in the sector included Leads Biolabs-B (+19.3%), Sihuan Pharmaceutical (+17.9%), and Tigermed (+7.6%), while the bottom five decliners included Medlive Technology (-16.2%) and Laekna-B (-14.1%) [4][29]. Summary by Sections Market Performance - The report indicates that various sub-sectors within the healthcare market have experienced declines, with pharmaceutical distribution down by 0.3%, internet healthcare down by 2.1%, and medical devices down by 5.0% [4][28]. Company Updates - Rongchang Biopharmaceutical announced a revenue forecast of 3.25 billion yuan for 2025, representing a year-on-year increase of 89%, and has turned a profit [11]. - A collaboration agreement was signed between CSPC Pharmaceutical and AstraZeneca, involving a total payment of $18.5 billion for the licensing of GLP-1 long-acting assets [11]. - AstraZeneca plans to invest $15 billion in China by 2030, focusing on expanding drug manufacturing and R&D capabilities [12]. - Kangzheng Pharmaceutical's lebrikizumab cream has been approved for the treatment of non-segmental vitiligo in patients aged 12 and older [12]. Regulatory Developments - The National Health Commission approved a pilot program for internet-based first consultations in Beijing, which is expected to accelerate prescription outflow [13].

2、国家统计局、中国物流与采购联合会31日发布2026年1月份中国采购经理指数。数据显示，2026年1 月份中国制造业采购经理指数为49.3%，比上月下降0.8个百分点。 3、香港特区政府财政司司长陈茂波2月1日表示，海外企业和投资者对投资香港的信心正在加强。去年 海内外企业的驻港公司以及香港的初创公司数目均大增逾一成，分别超过11000家和5200家。另据一些 外国商会最近所做的调查，其大部分会员企业对香港营商前景感到乐观，正面预期的比例亦创近年新 高。在第十九届亚洲金融论坛举行期间，陈茂波先后与来自欧美和中东的政商领袖，以及内地和国际多 边组织代表会面，他们都不约而同指香港的前景正面，并涌现更多新机遇。 4、受获利回吐和短期期货交易者多头平仓等因素影响，国际黄金和白银价格1月30日继续大幅下跌，均 创下数十年来最大单日跌幅。分析人士认为，经历近一个月来金银价格暴涨，此次市场抛售在所难免。 此外芝加哥商品交易所于当地时间上周五宣布上调Comex黄金和白银期货的交易保证金要求。根据声 明，对于非高风险账户，黄金期货的保证金将从当前合约价值的6%提高至8%，高风险账户的保证金则 从6.6%上调至8.8%。白银方 ...